BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31164166)

  • 21. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
    Jin JO; Shinohara Y; Yu Q
    PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
    Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
    Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E; Lefebvre F; Qadri A; Muller S
    J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
    Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
    Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17 and CCR9
    Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
    Front Immunol; 2021; 12():721453. PubMed ID: 34539657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
    Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM
    Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic abnormalities exacerbate Sjögren's syndrome by and is associated with increased the population of interleukin-17-producing cells in NOD/ShiLtJ mice.
    Hwang SH; Park JS; Yang S; Jung KA; Choi J; Kwok SK; Park SH; Cho ML
    J Transl Med; 2020 May; 18(1):186. PubMed ID: 32370746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
    Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
    Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
    Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
    Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in a murine model of Sjögren's syndrome.
    Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
    Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.
    Li X; Xu B; Wang Y; Wei L
    Int J Clin Exp Pathol; 2014; 7(8):4886-94. PubMed ID: 25197359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
    Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
    J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.
    Roescher N; Lodde BM; Vosters JL; Tak PP; Catalan MA; Illei GG; Chiorini JA
    Oral Dis; 2012 Jan; 18(1):96-106. PubMed ID: 21914088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
    Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.